openPR Logo
Press release

Europe Topical Drug Delivery Market Report 2018 Companies Included: MedPharm Ltd, Janssen Inc., Galderma, Pharmatek, Stiefel, a GSK company, Tapemark, Acrux, Valeant Pharmaceuticals, Mylan, Hisamitsu Pharmaceutical Co., Inc., Others - Forecast 2024

09-24-2018 09:47 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Topical Drug Delivery Market

Topical Drug Delivery Market adds “Europe Topical Drug Delivery Market Report 2018 Companies Included: MedPharm Ltd, Janssen Inc., Galderma, Pharmatek, Stiefel, a GSK company, Tapemark, Acrux, Nitto Denko Corporation, Valeant Pharmaceuticals, Mylan, Hisamitsu Pharmaceutical Co., Inc., Others - Forecast 2024” reports to its database.

This report provides in depth study of “Europe Topical Drug Delivery Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Topical Drug Delivery Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report focuses on the Topical Drug Delivery Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Europe Topical Drug Delivery Market development in Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherlands and Rest of Europe.

Get Free Sample Copy of this Report at

The key companies involved in this market are:

• MedPharm
• Janssen Pharmaceuticals, Inc.,(Johnson & Johnson Services Inc.)
• Crescita TherapeuticsiNC.
• Galderma S.A.
• Biofarmitalia s.r.l
• Pharmatek Laboratories, Inc.
• Stiefel Laboratories, Inc.
• Tapemark
• Acrux Limited
• Nitto Denko Corporation
• Valeant Pharmaceuticals International, Inc.
• Skinvisible Pharmaceuticals, Inc.
• Mylan Pharmaceuticals Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Pocono Coated Products LLC
• TheraSolve NV.
• Samyang Biopharmaceuticals Corporation
• Lohmann Therapie-Systeme AG
• Prosollus Pharmaceuticals
• Easton Pharmaceuticals Inc.
• Novosis AG
• Antares Pharma, Inc.
• Endo Pharmaceuticals Inc.
• Transdermal Technologies, Inc.
• Sheffield Pharmaceuticals, Inc.
• Solvay
• 3M Drug Delivery Systems.

Order a Copy of Europe Topical Drug Delivery Market 2018 Report at

Market Segmentation: Europe Topical Drug Delivery Market

On the basis of product type:

• Transdermal Drug Delivery Devices
• Topical Drug Delivery Formulations

On the basis of end users:

• Hospitals
• Home Healthcare
• Clinics
• Diagnostic Centers
• Others

Based on country:

• Germany
• France
• United Kingdom
• Belgium
• Switzerland
• Italy
• Spain
• Russia
• Turkey
• Netherlands
• Rest of Europe

Market Analysis: Europe Topical Drug Delivery Market

Europe Topical Drug Delivery Market is expected to reach USD 60.3 billion by 2024 from USD 31.3 billion in 2016, growing at a CAGR of 8.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Frequently Asked Questions:

- What will the market size be in 2024?
- What are the key factors driving the global market?
- What are the challenges to market growth?
- Who are the key players in the market?
- What are the market opportunities and threats faced by the key players?
- What will be the growth rate in 2024?
- Which strategies are used by top players in the Europe Topical Drug Delivery Market?

Download Detailed TOC at

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research
Tel: +1-888-387-281

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Topical Drug Delivery Market Report 2018 Companies Included: MedPharm Ltd, Janssen Inc., Galderma, Pharmatek, Stiefel, a GSK company, Tapemark, Acrux, Valeant Pharmaceuticals, Mylan, Hisamitsu Pharmaceutical Co., Inc., Others - Forecast 2024 here

News-ID: 1257330 • Views: 228

More Releases from Data Bridge Market Research

Radiotherapy Market is Booming Worldwide With CIVCO Medical Solutions, Brainlab …
Global Radiotherapy Market is expected to reach at a CAGR of 7.7% in the forecast period of 2018 to 2025. Global Radiotherapy Market, By Therapy (Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Softwares, Systemic Radiotherapy), By Application (Prostrate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) –
Cable Assembly Market Quantitative Analysis By TE Connectivity, Molex, LLC, W. L …
The cable assembly report aids in achieving an extreme sense of evolving industry movements before the competitors. This market research report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. It becomes easy to analyse the actions of key players and its effect on the sales, import, export, revenue and CAGR values with this cable assembly report. The report is also a helpful source of assistance
Aroma Chemicals Market 2019:Quantitative Analysis By Hindustan Mint & Agro Produ …
The market analysis of aroma chemicals market report provides an examination of various market segments that are supposed to witness the fastest development amid the estimated forecast frame. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The best tools have been adopted to generate this report which is SWOT
Industrial Communication Market 2019:Industry Analysis By OMRON Corporation, Sch …
Global industrial communication market is set to witness a healthy CAGR of 11.12% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing adoption of industrial internet of things and increasing demand for wireless networks are the factor for the growth of this market. Industrial communication report is a well-generated market report which helps achieve comprehensive analysis of the market

All 5 Releases

More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample - Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning